Version 5.4
| Bos taurus Gene: CHUK | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Summary | |||||||||||||||||||||||||||||
| InnateDB Gene | IDBG-638708.3 | ||||||||||||||||||||||||||||
| Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||
| Gene Symbol | CHUK | ||||||||||||||||||||||||||||
| Gene Name | Inhibitor of nuclear factor kappa-B kinase subunit alpha | ||||||||||||||||||||||||||||
| Synonyms | |||||||||||||||||||||||||||||
| Species | Bos taurus | ||||||||||||||||||||||||||||
| Ensembl Gene | ENSBTAG00000007591 | ||||||||||||||||||||||||||||
| Encoded Proteins |
Inhibitor of nuclear factor kappa-B kinase subunit alpha
|
||||||||||||||||||||||||||||
| Protein Structure | |||||||||||||||||||||||||||||
| Useful resources | Stemformatics EHFPI ImmGen | ||||||||||||||||||||||||||||
| InnateDB Annotation from Orthologs | |||||||||||||||||||||||||||||
| Summary |
[Mus musculus] Chuk has a key role in the negative feedback of NF-kB canonical signalling by orchestrating the assembly of the A20 ubiquitin-editing complex to limit inflammatory gene activation in response to proinflammatory stimuli such as Tnf and Il1.
[Mus musculus] Epithelial cell-intrinsic Chuk expression and Tslp regulate group 3 innate lymphoid cell responses required to maintain intestinal barrier immunity.
[Homo sapiens] CHUK is part of the inhibitor kappaB kinase (IKK) complex that phosphorylates IRS1 at Ser(312) and this contributes to the insulin resistance mediated by activation of inflammatory pathways.
[Homo sapiens] CHUK (IKK-alpha) is part of the IKK signalosome that phosphorylates NFKBIA and NFKBIB, leading to activation of NF-kappaB.
[Homo sapiens] CHUK (IKKalpha) phosphorylates CREBBP (CBP), regulating the CBP-mediated crosstalk between NF-kappaB and p53, a critical factor in the promotion of cell proliferation and tumor growth.
[Homo sapiens] CHUK is a unique molecule involved in TLR7/9-MyD88-dependent type I IFN production through dendritic cell subset-specific mechanisms.
[Homo sapiens] CHUK has a key role in the negative feedback of NF-kB canonical signalling by orchestrating the assembly of the A20 ubiquitin-editing complex to limit inflammatory gene activation in response to proinflammatory stimuli such as TNF and IL1. (Demonstrated in mouse)
[Homo sapiens] CHUK is required in dendritic cells to prime adaptive immunity to Listeria monocytogenes.
[Homo sapiens] GNB2L1 (RACK1) negatively regulates NFκB activation by interacting with CHUK and IKBKB. The interaction interferes with the recruitment of the IKK complex to TRAF2 .
[Homo sapiens] DDX3X initiates a multifaceted cellular program involving dynamic associations with hepatitis C virus (HCV) RNA and proteins, CHUK, stress granules, and lipid droplet surfaces for its crucial role in the HCV life cycle.
|
||||||||||||||||||||||||||||
| Entrez Gene | |||||||||||||||||||||||||||||
| Summary |
This gene does not have any Entrez summary - the following is the summary from its human ortholog ENSG00000213341:
This gene encodes a member of the serine/threonine protein kinase family. The encoded protein, a component of a cytokine-activated protein complex that is an inhibitor of the essential transcription factor NF-kappa-B complex, phosphorylates sites that trigger the degradation of the inhibitor via the ubiquination pathway, thereby activating the transcription factor. [provided by RefSeq, Jul 2008] |
||||||||||||||||||||||||||||
| Gene Information | |||||||||||||||||||||||||||||
| Type | Protein coding | ||||||||||||||||||||||||||||
| Genomic Location | Chromosome 26:20966010-21008277 | ||||||||||||||||||||||||||||
| Strand | Reverse strand | ||||||||||||||||||||||||||||
| Band | |||||||||||||||||||||||||||||
| Transcripts |
|
||||||||||||||||||||||||||||
| Interactions | |||||||||||||||||||||||||||||
| Number of Interactions |
This gene and/or its encoded proteins are associated with 5 experimentally validated interaction(s) in this database.
They are also associated with 164 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||
| Gene Ontology | |||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||
| Biological Process |
|
||||||||||||||||||||||||||||
| Cellular Component |
|
||||||||||||||||||||||||||||
| Orthologs | |||||||||||||||||||||||||||||
|
Species
Mus musculus
Homo sapiens
|
Gene ID
Gene Order
|
||||||||||||||||||||||||||||
| Pathways | |||||||||||||||||||||||||||||
| NETPATH | |||||||||||||||||||||||||||||
| REACTOME |
DAP12 interactions pathway
NOD1/2 Signaling Pathway pathway
Signaling by EGFR pathway
GAB1 signalosome pathway
Toll Like Receptor 2 (TLR2) Cascade pathway
AKT phosphorylates targets in the cytosol pathway
TRIF-mediated TLR3/TLR4 signaling pathway
Toll Like Receptor 3 (TLR3) Cascade pathway
Signaling by PDGF pathway
Activated TLR4 signalling pathway
Toll Like Receptor 7/8 (TLR7/8) Cascade pathway
MyD88-independent cascade pathway
Signaling by ERBB4 pathway
Cytosolic sensors of pathogen-associated DNA pathway
Toll Like Receptor 9 (TLR9) Cascade pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
MyD88:Mal cascade initiated on plasma membrane pathway
Toll Like Receptor 5 (TLR5) Cascade pathway
IKK complex recruitment mediated by RIP1 pathway
Signaling by FGFR pathway
Cytokine Signaling in Immune system pathway
Downstream TCR signaling pathway
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 pathway
Downstream signaling events of B Cell Receptor (BCR) pathway
PI3K events in ERBB2 signaling pathway
Immune System pathway
Constitutive PI3K/AKT Signaling in Cancer pathway
Signaling by the B Cell Receptor (BCR) pathway
Signaling by ERBB2 pathway
Toll-Like Receptors Cascades pathway
Signal Transduction pathway
TRAF6 mediated NF-kB activation pathway
Signaling by EGFR in Cancer pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways pathway
PI-3K cascade pathway
Toll Like Receptor 10 (TLR10) Cascade pathway
Toll Like Receptor TLR6:TLR2 Cascade pathway
NGF signalling via TRKA from the plasma membrane pathway
PI3K events in ERBB4 signaling pathway
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation pathway
Downstream signaling of activated FGFR pathway
Signalling by NGF pathway
FCERI mediated NF-kB activation pathway
PI3K/AKT Signaling in Cancer pathway
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation pathway
Role of LAT2/NTAL/LAB on calcium mobilization pathway
Adaptive Immune System pathway
Toll Like Receptor TLR1:TLR2 Cascade pathway
Activation of NF-kappaB in B cells pathway
MyD88 dependent cascade initiated on endosome pathway
Downstream signal transduction pathway
TAK1 activates NFkB by phosphorylation and activation of IKKs complex pathway
PIP3 activates AKT signaling pathway
Signaling by SCF-KIT pathway
Innate Immune System pathway
PI3K/AKT activation pathway
Interleukin-1 signaling pathway
ZBP1(DAI) mediated induction of type I IFNs pathway
RIP-mediated NFkB activation via ZBP1 pathway
Signaling by Interleukins pathway
DAP12 signaling pathway
Disease pathway
Signaling by FGFR in disease pathway
Toll Like Receptor 4 (TLR4) Cascade pathway
Fc epsilon receptor (FCERI) signaling pathway
IRAK1 recruits IKK complex pathway
MyD88 cascade initiated on plasma membrane pathway
TCR signaling pathway
|
||||||||||||||||||||||||||||
| KEGG | |||||||||||||||||||||||||||||
| INOH | |||||||||||||||||||||||||||||
| PID NCI | |||||||||||||||||||||||||||||
| Pathway Predictions based on Human Orthology Data | |||||||||||||||||||||||||||||
| NETPATH |
TGF_beta_Receptor pathway
TNFalpha pathway
TCR pathway
BCR pathway
IL1 pathway
IL4 pathway
RANKL pathway
Leptin pathway
TWEAK pathway
IL11 pathway
|
||||||||||||||||||||||||||||
| REACTOME |
AKT phosphorylates targets in the cytosol pathway
PIP3 activates AKT signaling pathway
DAP12 signaling pathway
DAP12 interactions pathway
RIP-mediated NFkB activation via ZBP1 pathway
ZBP1(DAI) mediated induction of type I IFNs pathway
TRAF6 mediated NF-kB activation pathway
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 pathway
RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways pathway
IKK complex recruitment mediated by RIP1 pathway
TAK1 activates NFkB by phosphorylation and activation of IKKs complex pathway
MyD88-independent cascade pathway
Toll Like Receptor 3 (TLR3) Cascade pathway
IRAK1 recruits IKK complex pathway
MyD88:Mal cascade initiated on plasma membrane pathway
Toll Like Receptor TLR1:TLR2 Cascade pathway
Toll Like Receptor TLR6:TLR2 Cascade pathway
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation pathway
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation pathway
MyD88 dependent cascade initiated on endosome pathway
Toll Like Receptor 9 (TLR9) Cascade pathway
MyD88 cascade initiated on plasma membrane pathway
Toll Like Receptor 10 (TLR10) Cascade pathway
Toll Like Receptor 4 (TLR4) Cascade pathway
Toll Like Receptor 5 (TLR5) Cascade pathway
NOD1/2 Signaling Pathway pathway
Downstream TCR signaling pathway
Interleukin-1 signaling pathway
Activation of NF-kappaB in B cells pathway
PI3K/AKT activation pathway
GAB1 signalosome pathway
Signaling by EGFR pathway
PI3K events in ERBB4 signaling pathway
Signaling by ERBB4 pathway
PI3K events in ERBB2 signaling pathway
Signaling by ERBB2 pathway
PI-3K cascade pathway
Signaling by FGFR pathway
Signaling by SCF-KIT pathway
Downstream signal transduction pathway
Signaling by PDGF pathway
Constitutive PI3K/AKT Signaling in Cancer pathway
Signaling by FGFR in disease pathway
FCERI mediated NF-kB activation pathway
Signalling by NGF pathway
Toll Like Receptor 7/8 (TLR7/8) Cascade pathway
Signaling by EGFR in Cancer pathway
Downstream signaling of activated FGFR pathway
TCR signaling pathway
Role of LAT2/NTAL/LAB on calcium mobilization pathway
Cytokine Signaling in Immune system pathway
Innate Immune System pathway
Toll Like Receptor 2 (TLR2) Cascade pathway
Toll-Like Receptors Cascades pathway
Fc epsilon receptor (FCERI) signaling pathway
Signal Transduction pathway
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways pathway
Adaptive Immune System pathway
Immune System pathway
Signaling by Interleukins pathway
NGF signalling via TRKA from the plasma membrane pathway
Activated TLR4 signalling pathway
PI3K/AKT Signaling in Cancer pathway
TRIF-mediated TLR3/TLR4 signaling pathway
Cytosolic sensors of pathogen-associated DNA pathway
Signaling by the B Cell Receptor (BCR) pathway
Downstream signaling events of B Cell Receptor (BCR) pathway
Disease pathway
|
||||||||||||||||||||||||||||
| KEGG |
Acute myeloid leukemia pathway
T cell receptor signaling pathway pathway
Toll-like receptor signaling pathway pathway
MAPK signaling pathway pathway
Small cell lung cancer pathway
Adipocytokine signaling pathway pathway
Apoptosis pathway
Prostate cancer pathway
Chronic myeloid leukemia pathway
B cell receptor signaling pathway pathway
Pancreatic cancer pathway
Chemokine signaling pathway pathway
Pathways in cancer pathway
RIG-I-like receptor signaling pathway pathway
NOD-like receptor signaling pathway pathway
Cytosolic DNA-sensing pathway pathway
Osteoclast differentiation pathway
Toxoplasmosis pathway
Hepatitis C pathway
Chagas disease (American trypanosomiasis) pathway
Acute myeloid leukemia pathway
Epithelial cell signaling in Helicobacter pylori infection pathway
Apoptosis pathway
MAPK signaling pathway pathway
Small cell lung cancer pathway
B cell receptor signaling pathway pathway
Prostate cancer pathway
T cell receptor signaling pathway pathway
Toll-like receptor signaling pathway pathway
Chronic myeloid leukemia pathway
Adipocytokine signaling pathway pathway
Pancreatic cancer pathway
Chemokine signaling pathway pathway
Pathways in cancer pathway
RIG-I-like receptor signaling pathway pathway
NOD-like receptor signaling pathway pathway
Cytosolic DNA-sensing pathway pathway
Chagas disease (American trypanosomiasis) pathway
Osteoclast differentiation pathway
Shigellosis pathway
Toxoplasmosis pathway
Hepatitis C pathway
|
||||||||||||||||||||||||||||
| INOH |
CD4 T cell receptor signaling pathway
IL-7 signaling pathway
IL-1 signaling pathway pathway
Toll-like receptor signaling pathway pathway
JAK STAT pathway and regulation pathway
B cell receptor signaling pathway
EPO signaling pathway pathway
VEGF signaling pathway pathway
TNFR1 signaling pathway pathway
|
||||||||||||||||||||||||||||
| PID NCI |
TCR signaling in naïve CD8+ T cells
Class I PI3K signaling events mediated by Akt
Validated nuclear estrogen receptor alpha network
TCR signaling in naïve CD4+ T cells
IL1-mediated signaling events
TNF receptor signaling pathway
TRAIL signaling pathway
FoxO family signaling
p75(NTR)-mediated signaling
BCR signaling pathway
Canonical NF-kappaB pathway
Validated transcriptional targets of TAp63 isoforms
Fc-epsilon receptor I signaling in mast cells
Alternative NF-kappaB pathway
Endogenous TLR signaling
HIV-1 Nef: Negative effector of Fas and TNF-alpha
Osteopontin-mediated events
FAS (CD95) signaling pathway
|
||||||||||||||||||||||||||||
| Cross-References | |||||||||||||||||||||||||||||
| SwissProt | |||||||||||||||||||||||||||||
| TrEMBL | |||||||||||||||||||||||||||||
| UniProt Splice Variant | |||||||||||||||||||||||||||||
| Entrez Gene | |||||||||||||||||||||||||||||
| UniGene | Bt.102018 Bt.63925 | ||||||||||||||||||||||||||||
| RefSeq | NM_174021 | ||||||||||||||||||||||||||||
| HUGO | |||||||||||||||||||||||||||||
| OMIM | |||||||||||||||||||||||||||||
| CCDS | |||||||||||||||||||||||||||||
| HPRD | |||||||||||||||||||||||||||||
| IMGT | |||||||||||||||||||||||||||||
| EMBL | |||||||||||||||||||||||||||||
| GenPept | |||||||||||||||||||||||||||||
| RNA Seq Atlas | |||||||||||||||||||||||||||||